Mar 162016
Talent4Boards - Great Talent builds Great Boards
– USA, CA – Five Prime Therapeutics, Inc. (Nasdaq:FPRX), a clinical-stage biotechnology company focused on discovering and developing innovative immuno-oncology protein therapeutics, announced changes to its Board of Directors.… => Read more
Five Prime Therapeutics appoints CEO Rusty Williams as Chairman of the Board
From:: Five Prime Therapeutics appoints CEO Rusty Williams as Chairman of the Board
Sorry, the comment form is closed at this time.